Home/Filings/4/0001209191-20-024296
4//SEC Filing

NEA 14 GP, LTD 4

Accession 0001209191-20-024296

CIK 0001442836other

Filed

Apr 12, 8:00 PM ET

Accepted

Apr 13, 9:09 PM ET

Size

11.7 KB

Accession

0001209191-20-024296

Insider Transaction Report

Form 4
Period: 2020-04-09
Transactions
  • Other

    Common Stock

    2020-04-094,000,0007,959,520 total(indirect: See Note 2)
  • Other

    Common Stock

    2020-04-0940,0000 total
  • Other

    Common Stock

    2020-04-09+40,00040,000 total
Transactions
  • Other

    Common Stock

    2020-04-09+40,00040,000 total
  • Other

    Common Stock

    2020-04-0940,0000 total
  • Other

    Common Stock

    2020-04-094,000,0007,959,520 total(indirect: See Note 2)
Footnotes (5)
  • [F1]New Enterprise Associates 14, L.P. ("NEA 14") made a pro rata distribution for no consideration of an aggregate of 4,000,000 shares of Common Stock of the Issuer to its general partner and its limited partners on April 9, 2020.
  • [F2]The shares are directly held by NEA 14 and are indirectly held by the Reporting Person, the sole general partner of NEA 14, NEA 14 GP, LTD ("NEA 14 LTD"), the sole general partner of the Reporting Person and each of the individual directors of NEA 14 LTD (the Reporting Person, NEA 14 LTD and the individual directors of NEA 14 LTD (collectively, "Directors") together, the "NEA 14 Indirect Reporting Persons"). The Directors of NEA 14 LTD are Forest Baskett, Anthony A. Florence, Patrick J. Kerins, Scott D. Sandell and Peter W. Sonsini. The NEA 14 Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 shares in which the NEA 14 Indirect Reporting Persons have no pecuniary interest.
  • [F3]The Reporting Person received 40,000 shares of Common Stock of the Issuer in the distribution by NEA 14 on April 9, 2020.
  • [F4]The shares are directly held by the Reporting Person and indirectly held by NEA 14 LTD, the sole general partner of the Reporting Person, and the Directors of NEA 14 LTD (NEA 14 LTD and the Directors of NEA 14 LTD together, the "NEA Partners 14 Indirect Reporting Persons"). The NEA Partners 14 Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA Partners 14 shares in which the NEA Partners 14 Indirect Reporting Persons have no pecuniary interest.
  • [F5]The Reporting Person made a pro rata distribution for no consideration of an aggregate of 40,000 shares of Common Stock of the Issuer to its limited partners on April 9, 2020.

Issuer

Mersana Therapeutics, Inc.

CIK 0001442836

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001551532

Filing Metadata

Form type
4
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 9:09 PM ET
Size
11.7 KB